Skip to main content
OpenTrials

Clinical trial condition

Tetanus

Explore clinical trials studying Tetanus. Study availability and eligibility vary by location and protocol.

220 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Tetanus trial results

Completed

Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

NCT01248884

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations
  • GSK Investigational Site Santo Domingo, Dominican Republic
  • GSK Investigational Site Santo Domingo, Distrito Nacional, Dominican Republic
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
View all 16 locations
View Trial Details
Completed

Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants

NCT01090453

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
Locations
  • GSK Investigational Site Vancouver, British Columbia, Canada
  • GSK Investigational Site Winnipeg, Manitoba, Canada
  • GSK Investigational Site Hamilton, Ontario, Canada
  • GSK Investigational Site Aix-en-Provence, France
View all 34 locations
View Trial Details
Completed

US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease

NCT00282295

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +12 more
Locations
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Fountain Valley, California, United States
  • GSK Investigational Site Golden, Colorado, United States
View all 24 locations
View Trial Details
Completed

Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children

NCT01245049

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations
  • GSK Investigational Site St Austell, Cornwall, United Kingdom
  • GSK Investigational Site Southampton, Hampshire, United Kingdom
  • GSK Investigational Site Axbridge, Somerset, United Kingdom
  • GSK Investigational Site Taunton, Somerset, United Kingdom
View all 13 locations
View Trial Details
Completed

Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years

NCT00346073

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +12 more
Locations
  • GSK Investigational Site Huntsville, Alabama, United States
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Mesa, Arizona, United States
View all 42 locations
View Trial Details

Related conditions